isabelobrien, Author at European Medical Journal - Page 27 of 29

Pharma: the social butterfly

The internet is a jungle, tangled and overgrown, dense with information overload. Among the unkempt chaos lies social media: a treasure trove of possibilities for the pharmaceutical industry.

Talking to Eric Bouilloux

Eric Bouilloux, Chief of Staff, Global Medical Affairs, Ipsen, discusses his career path to his current position and also share his views on the evolution of medical affairs.

Unitary Patent – what is it and why the hold up?

Establishing a brand-new multinational legal system was never going to be easy, but why has it taken so long and what is the outlook?

Designing a new approach to UX

In an era when UX is becoming fundamental to businesses globally, the role of design teams in pharma companies is taking on a whole new meaning.

The developing world: an innovation hub

Many of the most transformative innovations are taking place in the developing world on an increasingly regular basis. This article explores this phenomenon in healthcare and the key lessons pharma can take when creating their own innovative products.

Creativity For Good | Creativity For Growth

Pharma is seeing a host of ground-breaking innovations, with companies developing new technologies that are changing patients’ lives and helping to develop a more patient-centric industry

Should pharma tune into the ‘earfluence’ of the podcast?

As podcasts become a popular medium for learning and knowledge sharing, should the pharmaceutical industry give them a go as a way to educate patients and healthcare professionals?

Lifting the curtain on patient data

How can the pharmaceutical industry lead the way in data transparency and give more patients the confidence to share their records with researchers?

So long to the sales rep? Pharma sales is changing

It has become clear that healthcare professionals don’t want to be sold to. They want to be partners with industry and be treated as such. How can the rep model evolve to stay in line with expectations?

A proactive approach to patient centricity

The increasing focus on patient centricity in recent years has ensured pharmaceutical companies are far more in sync with the issues that patients’ face on a day-to-day basis than ever before; however, translating these insights into treatment improvements remains a challenge.